Incremental prognostic value of speckle tracking echocardiography and early follow‐up echo assessment in predicting left ventricular recovery after reperfusion for ST‐segment elevation myocardial infarction (STEMI)

Abstract

AbstractPurposeUp to 50% of patients do not achieve significant left ventricular ejection fraction (LVEF) recovery after primary percutaneous intervention (PPCI) for STEMI. We aimed to identify the echocardiographic predictors for LVEF recovery and assess the value of early follow‐up echocardiography (Echo) in risk assessment of post‐myocardial infarction (MI) patients.MethodsOne hundred one STEMI patients undergoing PPCI were enrolled provided EF below 50%. Baseline echocardiography assessed LVEF, volumes, wall motion score index (WMSI), global longitudinal strain (GLS), global circumferential strain (GCS), and E/e’. Follow‐up echocardiography after 6 weeks reassessed left ventricular volumes, LVEF and GLS.GCS was not assessed at follow up. Patients were classified into recovery and non‐recovery groups. Predictors of LVEF recovery and major adverse cardiovascular events (MACE) at 6 months were analysed.ResultsThe mean change of EF was 8.04 ± 3.32% in group I versus ‐.39 ± 5.09 % in group II (p < .001). Recovered patients had better baseline GLS, baseline GCS, E/e’, and follow‐up GLS. Multivariate regression analysis revealed E/e’, GCS, and follow‐up GLS after 6 weeks to be strong independent predictors for LVEF recovery. Composite MACE was considerably higher in group II (32.7% vs. 4.1%, p < .001) mainly driven by higher heart failure hospitalisation Multivariate regression analysis revealed baseline GLS, E/e’, and ejection fraction (EF) percentage recovery as strong independent predictors for MACE.ConclusionsMultiparametric echocardiographic approach incorporating LVEF, strain parameters, and diastolic function could allow early optimal risk stratification after STEMI treated with PPCI. Follow‐up GLS and LVEF percentage change are the strongest predictors for early LV recovery and long term clinical outcome, respectively.